US biotech Cogent Biosciences (Nasdaq: COGT) has seen its share price more than double after its lead drug, bezuclastinib, ...

Japan’s Otsuka has announced positive findings from a 12-month interim analysis of sibeprenlimab for the treatment of ...

US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...

Danish CNS specialist Lundbeck today announced results, that showed total revenue grew by +14% CER1 (+13% DKK) to 18,537 ...

Cambridge, USA-based AI-driven biotech Insilico Medicine has announced a research collaboration with Eli Lilly, under which ...

US biopharma Madrigal has announced positive two-year data from the open-label compensated metabolic dysfunction-associated ...

Canadian genetic medicines company enGene Holdings saw its shares rocket as much as 65% to $9.93 in pre-market trading, after ...

Switzerland’s Idorsia has announced the publication of a new analysis from the landmark Phase III PRECISION study.

In today’s rapidly evolving healthcare landscape, the journey from scientific discovery to patient access is more complex ...

South Korea-based Samsung Epis Holdings today announced the establishment of Epis NexLab Co, a new subsidiary that will focus ...

The US regulator is removing boxed warnings for cardiovascular disease, breast cancer and dementia from hormone replacement ...

Swiss pharma giant Novartis announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing ...